SQSTM1 and glomerulosclerosis: However, as discussed above, UA administration can regulate P62-mediated autophagy flux and sequentially inhibit the abnormal activation of the MDM2-Notch1 pathway, preventing podocyte death during the initial phases of glomerular injury and thus alleviating glomerulosclerosis.